BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 38657044)

  • 1. APLF facilitates interstrand DNA crosslink repair and replication fork protection to confer cisplatin resistance.
    Wu CK; Shiu JL; Wu CL; Hung CF; Ho YC; Chen YT; Tung SY; Yeh CF; Shen CH; Liaw H; Su WP
    Nucleic Acids Res; 2024 Jun; 52(10):5676-5697. PubMed ID: 38520407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNF4 sustains Myc-driven tumorigenesis by facilitating DNA replication.
    Her J; Zheng H; Bunting SF
    J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38530355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.
    Ma J; Ren D; Wang Z; Li W; Li L; Liu T; Ye Q; Lei Y; Jian Y; Ma B; Fan Y; Liu J; Gao Y; Jin X; Huang H; Li L
    Sci Adv; 2024 May; 10(21):eadk8908. PubMed ID: 38781342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TIMELESS and PARP1 interaction suppresses replication-associated DNA gap accumulation.
    Saldanha J; Rageul J; Patel JA; Phi AL; Lo N; Park JJ; Kim H
    Nucleic Acids Res; 2024 May; ():. PubMed ID: 38801073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INO80 haploinsufficiency inhibits colon cancer tumorigenesis via replication stress-induced apoptosis.
    Lee SA; Lee HS; Hur SK; Kang SW; Oh GT; Lee D; Kwon J
    Oncotarget; 2017 Dec; 8(70):115041-115053. PubMed ID: 29383140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction to 'Human CDK18 promotes replication stress signaling and genome stability'.
    Nucleic Acids Res; 2024 Jun; 52(10):6094-6095. PubMed ID: 38676951
    [No Abstract]   [Full Text] [Related]  

  • 7. The fork and the kinase: a DNA replication tale from a CHK1 perspective.
    González Besteiro MA; Gottifredi V
    Mutat Res Rev Mutat Res; 2015; 763():168-80. PubMed ID: 25795119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ATR-CHK1 signaling by ubiquitination of CLASPIN.
    Zhu X; Zheng XY; Gong P; Xu X
    Biochem Soc Trans; 2022 Oct; 50(5):1471-1480. PubMed ID: 36196914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP1 UFMylation ensures the stability of stalled replication forks.
    Gong Y; Wang Z; Zong W; Shi R; Sun W; Wang S; Peng B; Takeda S; Wang ZQ; Xu X
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2322520121. PubMed ID: 38657044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribose) binding to Chk1 at stalled replication forks is required for S-phase checkpoint activation.
    Min W; Bruhn C; Grigaravicius P; Zhou ZW; Li F; Krüger A; Siddeek B; Greulich KO; Popp O; Meisezahl C; Calkhoven CF; Bürkle A; Xu X; Wang ZQ
    Nat Commun; 2013; 4():2993. PubMed ID: 24356582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells.
    Tan Q; Xu X
    J Biol Chem; 2024 Apr; 300(6):107312. PubMed ID: 38657865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection.
    Rageul J; Lo N; Phi AL; Patel JA; Park JJ; Kim H
    Cell Rep; 2024 Mar; 43(3):113845. PubMed ID: 38393943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARM1 regulates replication fork speed and stress response by stimulating PARP1.
    Genois MM; Gagné JP; Yasuhara T; Jackson J; Saxena S; Langelier MF; Ahel I; Bedford MT; Pascal JM; Vindigni A; Poirier GG; Zou L
    Mol Cell; 2021 Feb; 81(4):784-800.e8. PubMed ID: 33412112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Catalytically Independent Function of Human DNA Polymerase Kappa Controls the Stability and Abundance of Checkpoint Kinase 1.
    Dall'Osto M; Pierini L; Valery N; Hoffmann JS; Pillaire MJ
    Mol Cell Biol; 2021 Oct; 41(11):e0009021. PubMed ID: 34398682
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.